Login / Signup

Complexity of Advanced Glycation End Products in Foods: Where Are We Now?

Yingdong ZhuHunter SnooksShengmin Sang
Published in: Journal of agricultural and food chemistry (2018)
Recent clinical trials indicate that consumption of dietary advanced glycation end products (AGEs) may promote the development of major chronic diseases. However, the outcomes of human studies have proven inconclusive as a result of estimates of the total AGE intake being taken with a single AGE in most of the studies. In this perspective, we summarized the major types of AGEs derived from proteins, nucleic acids, and phospholipids during food processing and suggested a panel of AGEs as markers to better measure the intake of total dietary AGEs in human studies.
Keyphrases
  • endothelial cells
  • clinical trial
  • case control
  • induced pluripotent stem cells
  • pluripotent stem cells
  • weight gain
  • risk assessment
  • insulin resistance
  • phase ii